Beijing Tongren Hospital is a famous institution which specializes in ophthalmology and otolaryngology. Its records state that it was established in 1886 by an American Methodist church.

During the past decade, Beijing Tongren Hospital conducted 111 clinical trials. In the 10-year time frame, 111 clinical trials started and 9 clinical trials were completed, i.e. on average, 8.1% percent of trials that started reached the finish line to date. In the past 5 years, 66 clinical trials started and 8 clinical trials were completed. i.e. 12.1% of trials that started reached the finish line.

Out of the total clinical trials conducted in "Beijing Tongren Hospital" #1 sponsor was "Beijing Tongren Hospital" with 56 trials, followed by "Chengdu Kanghong Biotech Co., Ltd." with 5 trials sponsored, "Peking Union Medical College Hospital" with 4 trials sponsored, "Hoffmann-La Roche" with 3 trials sponsored and "Allergan" with 3 trials sponsored. Other sponsors include 56 different institutions and companies that sponsored additional 57 trials in total.

In terms of collaborators to trials, out of the total clinical trials conducted in "Beijing Tongren Hospital" #1 collaborator was "Beijing Tongren Hospital" with 14 trials as a collaborator, "West China Hospital" with 5 trials as a collaborator, "Air Force Military Medical University, China" with 4 trials as a collaborator, "Beijing Hospital" with 4 trials as a collaborator and "Xuanwu Hospital, Beijing" with 4 trials as a collaborator. Other collaborators include 96 different institutions and companies that were collaborators in the rest 93 trials.

According to Clinical.Site data, the most researched conditions in "Beijing Tongren Hospital" are "Allergic Rhinitis" (5 trials), "Diabetes" (3 trials), "Vascular Diseases" (3 trials), "Alopecia Areata" (2 trials) and "Chronic Rhinosinusitis With Nasal Polyps" (2 trials). Many other conditions were trialed in "Beijing Tongren Hospital" in a lesser frequency.

Most popular intervention types in "Beijing Tongren Hospital" are "Drug" (79 trials), "Device" (21 trials), "Procedure" (18 trials), "Other" (10 trials) and "Biological" (9 trials). Other intervention types were less common.

The name of intervention was led by "Placebo" (11 trials), "Dexamethasone" (3 trials), "placebo" (3 trials), "Aflibercept" (2 trials) and "All-trans retinoic acid" (2 trials). Other intervention names were less common.

The vast majority of trials in "Beijing Tongren Hospital" are 129 trials for "All" genders and 2 trials for "Male" genders.

Currently, there are 40 active trials in "Beijing Tongren Hospital". 4 are not yet recruiting, 34 are recruiting, 1 are Active, not recruiting, and 1 are Enrolling by invitation. In total, there were 52 completed trials in Beijing Tongren Hospital, 2 suspended trials, and 2 terminated clinical trials to date.

Out of the total trials that were conducted in Beijing Tongren Hospital, 18 "Phase 1" clinical trials were conducted, 22 "Phase 2" clinical trials and 33 "Phase 3" clinical trials were conducted as well. "Phase 4" trials included 14 trials, and there were also 29 trials that are defined as “Not Applicable".